Search For "molnupiravir"
Updated : 1 day, 19 hours ago IST
New Delhi [India], January 18 (ANI): According to the revised guidelines issued by AIIMS, ICMR - COVID 19 National Task Force and Joint Monitoring Group (DGHS) under Union Health Ministry for management of adult COVID-19 patients, there is no evidence of injectable steroids in those who does
Updated : 6 days, 21 hours ago IST
New Delhi [India], January 12 (ANI): Antiviral drug Molnupiravir is not included in the National treatment task force for COVID-19, said Director General, Indian Council of Medical Research (ICMR) Balram Bhargava on Wednesday.
Updated : 1 week, 1 day ago IST
New Delhi [India], January 11 (ANI): Molnupiravir, an oral antiviral drug used in the treatment of COVID-19 should not be administered to the younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of COVID-19 Working Group of National Technical Advis
Updated : 1 week, 6 days ago IST
New Delhi [India], January 5 (ANI): Indian Council of Medical Research (ICMR) head Dr. Balram Bhargava on Wednesday stated that the oral anti-viral drug Molnupiravir capsules are not included in the national task force treatment for COVID-19 as it has side effects.
Updated : 3 weeks ago IST
Hyderabad (Telangana) [India], December 28 (ANI): Drugs Controller General of India (DCGI) on Tuesday approved Dr Reddy's laboratories for the emergency-use authorisation) to manufacture and market the oral anti-viral drug Molnupiravir capsules 200mg for the treatment of adult patients with
Updated : 3 weeks, 1 day ago IST
Mumbai (Maharashtra) [India], December 28 (ANI): Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch of Molnupiravir in the country for COVID-19 treatment.
Hyderabad (Telangana) [India], December 28 (ANI/PNN): Hyderabad, Optimus Pharma announced launching of their front line COVID-19 medication Molnupiravir in the Indian market, as they have received permission the restricted emergency use for Covid-19 drug.
New Delhi [India], December 28 (ANI): After the Union Health Ministry cleared two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, vaccine manufacturers welcomed the announcement and said that this would support the patients across India.
New Delhi [India], December 28 (ANI): Union Minister of Health and Family Welfare Mansukh Mandaviya on Tuesday announced the approval of two new indigenously developed vaccines and one anti-viral drug for the treatment of the adult patients of COVID-19 having a "high risk of progression o
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
Updated : 3 weeks, 2 days ago IST
New Delhi [India], December 27 (ANI): After reviewing all applications and data on antiviral pills, the Subject expert committee (SEC) a body under India's drug regulator will be meeting today for antiviral pill Molnupiravir recommendations, sources told to ANI.
Updated : 3 weeks, 5 days ago IST
Washington [US], December 23 (ANI): The US Food and Drug Administration (FDA) on Thursday said that it has granted an emergency use authorization for Merck's antiviral pill Molnupiravir that is used to treat COVID-19 patients.